LifeStance Health Group, Inc. Assets, Fair Value Disclosure
LifeStance Health Group, Inc. (LFST) had Assets, Fair Value Disclosure of $32.75 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2026-08-06
- 2026-06-30: Assets, Fair Value Disclosure $32.75M.
- 2026-03-31: Assets, Fair Value Disclosure $76.93M.
- 2025-12-31: Assets, Fair Value Disclosure $175.52M.
- 2025-09-30: Assets, Fair Value Disclosure $141.78M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $32.75M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $76.93M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $175.52M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $141.78M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $129.59M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $75.92M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $120.89M 10-K · filed 2026-02-25 |
| 2024-09-30 | $86.88M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $73.58M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $32.40M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $67.70M 10-K · filed 2025-02-27 |
| 2023-09-30 | $28.48M 10-Q · filed 2023-11-08 |
| 2022-12-31 | $4.43M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |